Trexquant Investment LP Dice Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$25.86 - $46.71 $293,873 - $530,812	-11,364 Reduced 52.11%	10,445 $485,000
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $310,802 - $385,490	11,931 Added 120.78%	21,809 $624,000
Q4 2022 Feb 13, 2023	SELL	$19.77 - $42.23 $152,762 - $326,311	-7,727 Reduced 43.89%	9,878 $308,000
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $73,233 - $110,803	-4,892 Reduced 21.75%	17,605 $357,000
Q2 2022 Aug 11, 2022	BUY	$13.19 - $22.1 $84,587 - $141,727	6,413 Added 39.87%	22,497 $349,000
Q1 2022 May 13, 2022	BUY	$14.54 - $25.02 $233,861 - $402,421	16,084 New	16,084 $308,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.